by Clinical Neuropsychologist Online | Monday, October 12, 2026 | Dementia
Abstract INTRODUCTION Self-reported sleep duration is associated with dementia-risk and vascular brain injury markers, including white matter hyperintensities (WMHs), yet how additional cerebrovascular pathology alters these relationships remains unclear. METHOD In a...
by Clinical Neuropsychologist Online | Monday, October 12, 2026 | Dementia
Abstract In the future, treatment of dementia will be personalized, targeted to contributing pathologies, rather than the clinical syndrome. Anti-amyloid drugs for Alzheimer’s disease are the first approved drugs; however, the impact of co‑pathology on the...
by Clinical Neuropsychologist Online | Monday, October 12, 2026 | Dementia
Abstract INTRODUCTION ATN-stratified cerebrospinal fluid (CSF) proteomic signals may partly reflect classifier tau immunoassays; reproducible non-tau signals and CSF–plasma differences remain unclear. METHODS We profiled CSF from 60 A+ Beijing patients with...
by Clinical Neuropsychologist Online | Monday, October 12, 2026 | Neuro Podcasts
Click here to read the transcript Today, I’m happy to sit down with Monica Corrado to explore Pathological Demand Avoidance, also referred to as Pervasive Drive for Autonomy (PDA), within the context of evaluation and clinical practice. We discuss how the intense need...
by Clinical Neuropsychologist Online | Monday, October 12, 2026 | Neuropsychology (general)
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | October 12, 2026 Neuro-General Previous Page
